pentobarbital decreases consequences of sufentanil SL by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Intently. Coadministration of CYP3A4 inducers may perhaps reduce sufentanil concentrations and efficacy, potentially precipitating withdrawal syndrome in people who may have designed Bodily dependence to sufentani